Page last updated: 2024-11-10

8,11,12-trihydroxy-5,9,14-eicosatrienoic acid

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

8,11,12-trihydroxy-5,9,14-eicosatrienoic acid: structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID5815889
SCHEMBL ID1479372
MeSH IDM0071298

Synonyms (6)

Synonym
SCHEMBL1479372
trioxilin a
5,9,14-eicosatrienoic acid, 8,11,12-trihydroxy-, (5z,9e,11s,12s,14z)-
94161-09-8
8,11,12-trihydroxy-5,9,14-eicosatrienoic acid
5,9,14-eicosatrienoic acid, 8,11,12-trihydroxy-
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (19)

TimeframeStudies, This Drug (%)All Drugs %
pre-19908 (42.11)18.7374
1990's7 (36.84)18.2507
2000's2 (10.53)29.6817
2010's2 (10.53)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other19 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]